Not to be confused with Anti-cholinesterase. Chemical substance that blocks the neurotransmitter acetylcholine in the central and the peripheral nervous system Anticholinergics (anticholinergic agent) are a group of substances that blocks the action of the neurotransmitter called acetylcholine (ACh) at synapses in the central and peripheral nervous system.[1][2] These agents inhibit the parasympathetic nervous system by selectively blocking the binding of ACh to its receptor in nerve cells. The nerve fibers of the parasympathetic system are responsible for the involuntary movement of smooth muscles present in the gastrointestinal tract, urinary tract, lungs, sweat glands, and many other parts of the body.[3] In broad terms, anticholinergics are divided into two categories in accordance with their specific targets in the central and peripheral nervous system and at the neuromuscular junction:[3] antimuscarinic agents, and antinicotinic agents (ganglionic blockers, neuromuscular blockers).[4] The term "anticholinergic" is typically used to refer to antimuscarinics which competitively inhibit the binding of ACh to muscarinic acetylcholine receptors; such agents do not antagonize the binding at nicotinic acetylcholine receptors at the neuromuscular junction, although the term is sometimes used to refer to agents which do so.[3][5] Contents 1 Medical uses 1.1 Physiological effects 2 Side effects 2.1 Toxicity 3 Pharmacology 4 Examples 5 Recreational uses 6 Plant sources 7 Use as a deterrent 8 References Medical uses[edit] Anticholinergic drugs are used to treat a variety of conditions: Dizziness (including vertigo and motion sickness-related symptoms) Extrapyramidal symptoms, a potential side-effect of antipsychotic medications Gastrointestinal disorders (e.g., peptic ulcers, diarrhea, pylorospasm, diverticulitis, ulcerative colitis, nausea, and vomiting) Genitourinary disorders (e.g., cystitis, urethritis, and prostatitis) Insomnia, although usually only on a short-term basis Respiratory disorders (e.g., asthma, chronic bronchitis, and chronic obstructive pulmonary disease [COPD]) Sinus bradycardia due to a hypersensitive vagus nerve Organophosphate based nerve agent poisoning, such as VX, sarin, tabun, and soman (atropine is favoured in conjunction with an oxime, usually pralidoxime)[6][7] Anticholinergics generally have antisialagogue effects (decreasing saliva production), and most produce some level of sedation, both being advantageous in surgical procedures.[8][9] Until the beginning of the 20th century anticholinergic drugs were widely used to treat psychiatric disorders.[10] Physiological effects[edit] Delirium Ocular symptoms (from eye drops): mydriasis, pupil dilation, and acute angle-closure glaucoma in those with shallow anterior chamber[11][12][13] Anhidrosis, dry mouth, dry skin Fever Constipation Tachycardia Urinary retention Cutaneous vasodilation[3] Clinically the most significant feature is delirium, particularly in the elderly, who are most likely to be affected by the toxidrome.[3] Side effects[edit] Long-term use may increase the risk of both cognitive and physical decline.[14][15] It is unclear whether they affect the risk of death generally.[14] However, in older adults they do appear to increase the risk of death.[16] Possible effects of anticholinergics include: Poor coordination Dementia[17] Decreased mucus production in the nose and throat; consequent dry, sore throat Dry-mouth with possible acceleration of dental caries Cessation of sweating; consequent decreased epidermal thermal dissipation leading to warm, blotchy, or red skin Increased body temperature Pupil dilation; consequent sensitivity to bright light (photophobia) Loss of accommodation (loss of focusing ability, blurred vision – cycloplegia) Double-vision Increased heart rate Tendency to be easily startled Urinary retention Urinary incontinence while sleeping Diminished bowel movement, sometimes ileus (decreases motility via the vagus nerve) Increased intraocular pressure; dangerous for people with narrow-angle glaucoma. Possible effects in the central nervous system resemble those associated with delirium, and may include: Confusion Disorientation Agitation Euphoria or dysphoria Respiratory depression Memory problems[18] Inability to concentrate Wandering thoughts; inability to sustain a train of thought Incoherent speech Irritability Mental confusion (brain fog) Wakeful myoclonic jerking Unusual sensitivity to sudden sounds Illogical thinking Photophobia Visual disturbances Periodic flashes of light Periodic changes in visual field Visual snow[citation needed] Restricted or "tunnel vision" Visual, auditory, or other sensory hallucinations Warping or waving of surfaces and edges Textured surfaces "Dancing" lines; "spiders", insects; form constants Lifelike objects indistinguishable from reality Phantom smoking Hallucinated presence of people not actually there Rarely: seizures, coma, and death Orthostatic hypotension (severe drop in systolic blood pressure when standing up suddenly) and significantly increased risk of falls in the elderly population.[19] Older patients are at a higher risk of experiencing CNS side effects. Toxicity[edit] An acute anticholinergic syndrome is reversible and subsides once all of the causative agents have been excreted. Reversible acetylcholinesterase inhibitor agents such as physostigmine can be used as an antidote in life-threatening cases. Wider use is discouraged due to the significant side effects related to cholinergic excess including seizures, muscle weakness, bradycardia, bronchoconstriction, lacrimation, salivation, bronchorrhea, vomiting, and diarrhea. Even in documented cases of anticholinergic toxicity, seizures have been reported after the rapid administration of physostigmine. Asystole has occurred after physostigmine administration for tricyclic antidepressant overdose, so a conduction delay (QRS > 0.10 second) or suggestion of tricyclic antidepressant ingestion is generally considered a contraindication to physostigmine administration.[20] Pharmacology[edit] Anticholinergics are classified according to the receptors that are affected: Antimuscarinic agents operate on the muscarinic acetylcholine receptors. The majority of anticholinergic drugs are antimuscarinics. Antinicotinic agents operate on the nicotinic acetylcholine receptors. The majority of these are non-depolarising skeletal muscle relaxants for surgical use that are structurally related to curare. Several are depolarizing agents. Examples[edit] Examples of common anticholinergics: Antimuscarinic agents Antipsychotics (clozapine, quetiapine)[21] Atropine Benztropine Biperiden Chlorpheniramine Certain SSRIs (Paroxetine)[21] Dicyclomine (Dicycloverine) Dimenhydrinate[21] Diphenhydramine[21] Doxepin Doxylamine Glycopyrrolate Glycopyrronium Hyoscyamine Ipratropium Orphenadrine Oxitropium Oxybutynin[21] Promethazine Propantheline bromide Scopolamine Solifenacin Tolterodine Tiotropium Tricyclic antidepressants (28 compounds with numerous trade names) Trihexyphenidyl Tropicamide[22] Umeclidinium Antinicotinic agents Bupropion – Ganglion blocker[23][24][25] Dextromethorphan - Cough suppressant and ganglion blocker[26][27][28] Doxacurium – Nondepolarizing skeletal muscular relaxant Hexamethonium – Ganglion blocker Mecamylamine – Ganglion blocker and occasional smoking cessation aid[29] Tubocurarine - Nondepolarizing skeletal muscular relaxant Plants of the family Solanaceae contain various anticholinergic tropane alkaloids, such as scopolamine, atropine, and hyoscyamine. Physostigmine is one of only a few drugs that can be used as an antidote for anticholinergic poisoning. Nicotine also counteracts anticholinergics by activating nicotinic acetylcholine receptors. Caffeine (although an adenosine receptor antagonist) can counteract the anticholinergic symptoms by reducing sedation and increasing acetylcholine activity, thereby causing alertness and arousal. Recreational uses[edit] When a significant amount of an anticholinergic is taken into the body, a toxic reaction known as acute anticholinergic syndrome may result. This may happen accidentally or intentionally as a consequence of recreational drug use. Anticholinergic drugs are usually considered the least enjoyable by many recreational drug users. In the context of recreational use, anticholinergics are often called deliriants.[22] Plant sources[edit] The most common plants containing anticholinergic alkaloids (including atropine, scopolamine, and hyoscyamine among others) are: Atropa belladonna (deadly nightshade) Brugmansia species Datura species Garrya species Hyoscyamus niger (henbane) Mandragora officinarum (mandrake) Use as a deterrent[edit] Several narcotic and opiate-containing drug preparations, such as those containing hydrocodone and codeine are combined with an anticholinergic agent to deter intentional misuse.[30] Examples include Hydromet/Hycodan (hydrocodone/homatropine), Lomotil (diphenoxylate/atropine) and Tussionex (hydrocodone polistirex/chlorpheniramine). However, it is noted that opioid/antihistamine combinations are used clinically for their synergistic effect in the management of pain and maintenance of dissociative anesthesia (sedation) in such preparations as Meprozine (meperidine/promethazine) and Diconal (dipipanone/cyclizine), which act as strong anticholinergic agents.[31] References[edit] ^ "Anticholinergics", Anticholinergic Agents, Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases, 2012, PMID 31643610, retrieved 2020-03-23, Anticholinergics have antisecretory activities and decrease nasal and bronchial secretions, salivation, lacrimation, sweating and gastric acid production, and can be used to decrease secretions in allergic and inflammatory diseases. Anticholinergics relax smooth muscle in the gastrointestinal tract, bladder and lung and can be used for gastrointestinal, urological or respiratory conditions associated with spasm and dysmotility. ^ Clinical Pharmacology [database online]. Tampa, FL: Gold Standard, Inc.; 2009. Drugs with Anticholinergic Activity. Prescriber's Letter 2011; 18 (12):271233. ^ a b c d e Migirov, A; Datta, AR (2020), "article-17683", Physiology, Anticholinergic Reaction, This book is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, a link is provided to the Creative Commons license, and any changes made are indicated., Treasure Island (FL): StatPearls Publishing, PMID 31536197, retrieved 2020-03-24 ^ Sharee A. Wiggins; Tomas Griebling. "Urinary Incontinence". Landon Center on Aging. Archived from the original on 2011-09-27. Retrieved 2011-07-09. Cite journal requires |journal= (help) ^ Authors: Mark Su, MD, MPH. Matthew Goldman, MD ; Section Editors: Stephen J Traub, MD. Michele M Burns, MD, MPH ;Deputy Editor:Jonathan Grayzel, MD, FAAEM. "Anticholinergic poisoning". UpToDate. Retrieved 2020-03-24.CS1 maint: uses authors parameter (link) ^ "NERVE AGENTS". fas.org. Retrieved 2020-07-27. ^ Nair, V. Priya; Hunter, Jennifer M. (2004-10-01). "Anticholinesterases and anticholinergic drugs". Continuing Education in Anaesthesia Critical Care & Pain. 4 (5): 164–168. doi:10.1093/bjaceaccp/mkh045. ISSN 1743-1816. ^ Page 592 in: Cahalan, Michael D.; Barash, Paul G.; Cullen, Bruce F.; Stoelting, Robert K. (2009). Clinical Anesthesia. Hagerstwon, MD: Lippincott Williams & Wilkins. ISBN 978-0-7817-8763-5. ^ Barash, Paul G. (2009). Clinical Anesthesia. ISBN 9780781787635. Archived from the original on 20 February 2017. Retrieved 8 December 2014. ^ Bangen, Hans: Geschichte der medikamentösen Therapie der Schizophrenie. Berlin 1992, ISBN 3-927408-82-4 ^ "ATROPINE- atropine sulfate solution/ drops". DailyMed. 2017-11-20. Retrieved 2020-03-28. ^ "MYDRIACYL- tropicamide solution/ drops". DailyMed. 2019-12-13. Retrieved 2020-03-28. ^ "MYDRIACYL- tropicamide solution/ drops". DailyMed. 2019-12-13. Retrieved 2020-03-28. ^ a b Fox, C; Smith, T; Maidment, I; Chan, WY; Bua, N; Myint, PK; Boustani, M; Kwok, CS; Glover, M; Koopmans, I; Campbell, N (September 2014). "Effect of medications with anti-cholinergic properties on cognitive function, delirium, physical function and mortality: a systematic review". Age and Ageing. 43 (5): 604–15. doi:10.1093/ageing/afu096. PMID 25038833. ^ Andre, L; Gallini, A; Montastruc, F; Montastruc, JL; Piau, A; Lapeyre-Mestre, M; Gardette, V (29 August 2019). "Association between anticholinergic (atropinic) drug exposure and cognitive function in longitudinal studies among individuals over 50 years old: a systematic review". European Journal of Clinical Pharmacology. 75 (12): 1631–1644. doi:10.1007/s00228-019-02744-8. PMID 31468067. S2CID 201675824. ^ Ruxton, K; Woodman, RJ; Mangoni, AA (2 March 2015). "Drugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: A systematic review and meta-analysis". British Journal of Clinical Pharmacology. 80 (2): 209–20. doi:10.1111/bcp.12617. PMC 4541969. PMID 25735839. ^ Falk, N; Cole, A; Meredith, TJ (15 March 2018). "Evaluation of Suspected Dementia". American Family Physician. 97 (6): 398–405. PMID 29671539. ^ Talan, Jamie (July–August 2008). "Common Drugs May Cause Cognitive Problems". Neurology Now. 4 (4): 10–11. doi:10.1097/01.NNN.0000333835.93556.d1. Archived from the original on 2019-06-26. Retrieved 26 June 2019. ^ "Lifeline Learning Center". Lifeline.theonlinelearningcenter.com. Archived from the original on 12 July 2012. Retrieved 8 December 2014. ^ Rosen, Peter, John A. Marx, Robert S. Hockberger, and Ron M. Walls. Rosen's Emergency Medicine: Concepts and Clinical Practice. 8th ed. Philadelphia, PA: Mosby Elsevier, 2014. ^ a b c d e "[113] How well do you know your anticholinergic (antimuscarinic) drugs? | Therapeutics Initiative". Therapeutics Initiative. 10 September 2018. Retrieved 20 September 2018. ^ a b Bersani, F. S.; Corazza, O.; Simonato, P.; Mylokosta, A.; Levari, E.; Lovaste, R.; Schifano, F. (2013). "Drops of madness? Recreational misuse of tropicamide collyrium; early warning alerts from Russia and Italy". General Hospital Psychiatry. 35 (5): 571–3. doi:10.1016/j.genhosppsych.2013.04.013. PMID 23706777. ^ Carroll FI, Blough BE, Mascarella SW, Navarro HA, Lukas RJ, Damaj MI (2014). "Bupropion and bupropion analogs as treatments for CNS disorders". Emerging Targets & Therapeutics in the Treatment of Psychostimulant Abuse. Adv. Pharmacol. Advances in Pharmacology. 69. pp. 177–216. doi:10.1016/B978-0-12-420118-7.00005-6. ISBN 9780124201187. PMID 24484978. ^ Dwoskin, Linda P. (29 January 2014). Emerging Targets & Therapeutics in the Treatment of Psychostimulant Abuse. Elsevier Science. pp. 177–216. ISBN 978-0-12-420177-4. Archived from the original on 20 March 2017. ^ Tasman, Allan; Kay, Jerald; Lieberman, Jeffrey A.; First, Michael B.; Maj, Mario (11 October 2011). Psychiatry. John Wiley & Sons. ISBN 978-1-119-96540-4. Archived from the original on 20 March 2017. ^ Damaj, M. I.; Flood, P; Ho, K. K.; May, E. L.; Martin, B. R. (2004). "Effect of Dextrometorphan and Dextrorphan on Nicotine and Neuronal Nicotinic Receptors: In Vitro and in Vivo Selectivity". Journal of Pharmacology and Experimental Therapeutics. 312 (2): 780–5. doi:10.1124/jpet.104.075093. PMID 15356218. S2CID 149958. ^ Lee, Jun-Ho; Shin, Eun-Joo; Jeong, Sang Min; Kim, Jong-Hoon; Lee, Byung-Hwan; Yoon, In-Soo; Lee, Joon-Hee; Choi, Sun-Hye; Lee, Sang-Mok; Lee, Phil Ho; Kim, Hyoung-Chun; Nah, Seung-Yeol (2006). "Effects of dextrorotatory morphinans on α3β4 nicotinic acetylcholine receptors expressed in Xenopus oocytes". European Journal of Pharmacology. 536 (1–2): 85–92. doi:10.1016/j.ejphar.2006.02.034. PMID 16563374. ^ Hernandez, S. C.; Bertolino, M; Xiao, Y; Pringle, K. E.; Caruso, F. S.; Kellar, K. J. (2000). "Dextromethorphan and Its Metabolite Dextrorphan Block α3β4 Neuronal Nicotinic Receptors". The Journal of Pharmacology and Experimental Therapeutics. 293 (3): 962–7. PMID 10869398. ^ Shytle, RD; Penny, E; Silver, AA; Goldman, J; Sanberg, PR (Jul 2002). "Mecamylamine (Inversine): an old antihypertensive with new research directions". Journal of Human Hypertension. 16 (7): 453–7. doi:10.1038/sj.jhh.1001416. PMID 12080428. ^ "NIH DailyMed – Hydromet Syrup". Dailymed.nlm.nih.gov. Archived from the original on 2011-05-23. Retrieved 2008-08-17. ^ Zacny, James P. (2003). "Characterizing the subjective, psychomotor, and physiological effects of a hydrocodone combination product (Hycodan) in non-drug-abusing volunteers". Psychopharmacology. 165 (2): 146–156. doi:10.1007/s00213-002-1245-5. PMID 12404072. S2CID 7835794. v t e Pharmacomodulation Types ♦ Enzyme: Inducer Inhibitor ♦ Ion channel: Opener Blocker ♦ Receptor: Agonist Partial agonist Antagonist Inverse agonist Positive allosteric modulator (PAM) Negative allosteric modulator (NAM) ♦ Transporter [Reuptake vs Efflux]: Enhancer (RE) Inhibitor (RI) Releaser (RA) ♦ Miscellaneous: Precursor Cofactor Classes Enzyme see Enzyme inhibition Ion channel See Ion channel modulators Receptor & transporter BA/M Adrenergic Adrenergic receptor agonist (α β (1 2)) Adrenergic receptor antagonist (α (1 2) β) Norepinephrine reuptake inhibitor (NRI) Dopaminergic Dopamine receptor agonist Dopamine receptor antagonist Dopamine reuptake inhibitor (DRI) Histaminergic Histamine receptor agonist Histamine receptor antagonist (H1 H2 H3) Serotonergic Serotonin receptor agonist Serotonin receptor antagonist (5-HT3) Serotonin reuptake inhibitor (SRI) AA GABAergic GABA receptor agonist GABA receptor antagonist GABA reuptake inhibitor (GRI) Glutamatergic Glutamate receptor agonist (AMPA) Glutamate receptor antagonist (NMDA) Glutamate reuptake inhibitor Cholinergic Acetylcholine receptor agonist (Muscarinic Nicotinic) Cholinesterase inhibitor Acetylcholine receptor antagonist (Muscarinic Nicotinic (Ganglionic Muscular)) Cannabinoidergic Cannabinoid receptor agonist Cannabinoid receptor antagonist Endocannabinoid enhancer (eCBE) Endocannabinoid reuptake inhibitor (eCBRI) Opioidergic Opioid modulator Opioid receptor agonist Opioid receptor antagonist Enkephalinase inhibitor Other Adenosine reuptake inhibitor (AdoRI) Angiotensin II receptor antagonist Endothelin receptor antagonist NK1 receptor antagonist Vasopressin receptor antagonist Miscellaneous Cofactor (see Enzyme cofactors) Precursor (see Amino acids) Medical uses v t e Drugs for functional gastrointestinal disorders (A03) Drugs for functional bowel disorders Antimuscarinics Tertiary amino group Oxyphencyclimine Camylofin Mebeverine Trimebutine Rociverine Dicycloverine Dihexyverine Difemerine Piperidolate Quaternary ammonium compounds Benzilone Mepenzolate Pipenzolate Glycopyrronium Oxyphenonium Penthienate Methantheline Propantheline Otilonium Tridihexethyl Isopropamide Hexocyclium Poldine Bevonium Diphemanil Tiemonium Prifinium Timepidium Fenpiverinium Phosphodiesterase inhibitors Papaverine Drotaverine Moxaverine Acting on serotonin receptors 5-HT3 antagonists Alosetron Cilansetron 5-HT4 agonists Mosapride Other Alverine Caroverine Chlorbenzoxamine Diisopromine Dimethylaminopropionylphenothiazine Fenpiprane Fenoverine Idanpramine Isometheptene Mentha piperita Phloroglucinol Pinaverium bromide Proxazole Silicones Tiropramide Trepibutone Trimethyldiphenylpropylamine Belladonna and derivatives (antimuscarinics) Tertiary amines: Atropine Hyoscyamine Quaternary ammonium compounds: Scopolamine Butylscopolamine Methylscopolamine Methylatropine Fentonium bromide Cimetropium bromide Propulsives Primarily dopamine antagonists Metoclopramide/Bromopride Clebopride Domperidone Alizapride 5-HT4 agonists Cinitapride Cisapride v t e Urologicals, including antispasmodics (G04B) Acidifiers Ammonium chloride Calcium chloride Urinary antispasmodics (primarily antimuscarinics) Darifenacin Desfesoterodine Emepronium Fesoterodine Flavoxate Imidafenacin Meladrazine Mirabegron Oxybutynin Propiverine Solifenacin Terodiline Tolterodine Trospium chloride Vibegron Other urologicals Urea analogues: Acetohydroxamic acid Salicylhydroxamic acid Other: Collagen Dimethyl sulfoxide Magnesium hydroxide Pentosan polysulfate Phenazopyridine Phenyl salicylate Succinimide v t e Skeletal muscle relaxants (M03) Peripherally acting (primarily antinicotinic, NMJ block) Non-depolarizing Curare alkaloids Alcuronium Dimethyltubocurarine Tubocurarine 4° ammonium agents ultra-short duration: Gantacurium short duration: Mivacurium Chandonium intermediate duration: Atracurium Cisatracurium Fazadinium Rocuronium Vecuronium long duration: Doxacurium Dimethyltubocurarine Pancuronium Pipecuronium Laudexium Gallamine unsorted: Hexafluronium (Hexafluorenium) Depolarizing Choline derivatives: Suxamethonium (Succinylcholine) Polyalkylene derivatives: Hexamethonium ACh release inhibitors Botulinum toxin Centrally acting Carbamic acid esters Carisoprodol Cyclarbamate Difebarbamate Febarbamate Meprobamate Phenprobamate Styramate Tybamate Benzodiazepines Bromazepam Diazepam Clonazepam Flunitrazepam Lorazepam Nitrazepam Temazepam Tetrazepam Nonbenzodiazepines Eszopiclone Thienodiazepines Etizolam Quinazolines Methaqualone Anticholinergics (Antimuscarinics) Cyclobenzaprine Orphenadrine Other Arbaclofen placarbil Baclofen Chlormezanone Chlorphenesin Chlorzoxazone Donepezil Eperisone Fenyramidol Flopropione Gabapentin GHB Inaperisone Lanperisone Mephenesin Mephenoxalone Metaxalone Methocarbamol Phenibut Pregabalin Pridinol Promoxolane Quinine Silperisone Thiocolchicoside Tizanidine Tolperisone Zoxazolamine Directly acting Dantrolene v t e Antiparkinson agents (N04) Dopaminergics DA precursors Levodopa# Melevodopa DA receptor agonists Apomorphine Bromocriptine Cabergoline Dihydroergocryptine Lisuride Pergolide Piribedil Pramipexole Ropinirole Rotigotine Talipexole MAO-B inhibitors Rasagiline Safinamide Selegiline COMT inhibitors Entacapone Opicapone Tolcapone AAAD inhibitors Benserazide Carbidopa# Anticholinergics Benzatropine Biperiden# Bornaprine Chlorphenoxamine Cycrimine Dexetimide Diphenhydramine Etanautine Etybenzatropine Mazaticol Metixene Orphenadrine Phenglutarimide Piroheptine Procyclidine Profenamine Tigloidine Trihexyphenidyl Tropatepine Others Amantadine Budipine Istradefylline Methylxanthines (e.g., caffeine) Rimantadine #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never to phase III v t e Drugs for obstructive airway diseases: asthma/COPD (R03) Adrenergics, inhalants Short-acting β2 agonists Bitolterol Carbuterol Fenoterol Isoetarine Pirbuterol Procaterol Reproterol Rimiterol Salbutamol (albuterol)#/Levosalbutamol (levalbuterol) Terbutaline Tulobuterol Long-acting β2 agonists Bambuterol Clenbuterol Formoterol/Arformoterol Salmeterol Salmefamol Ultra-long-acting β2 agonists Abediterol Carmoterol Indacaterol Olodaterol Vilanterol Other Epinephrine# Hexoprenaline Isoprenaline (isoproterenol) Orciprenaline (metaproterenol) Glucocorticoids Beclometasone# Betamethasone# Budesonide Ciclesonide Flunisolide Fluticasone propionate Mometasone Triamcinolone Anticholinergics/ muscarinic antagonist Aclidinium bromide Glycopyrronium bromide Ipratropium bromide# Oxitropium bromide Tiotropium bromide Umeclidinium bromide Mast cell stabilizers Cromoglicate Nedocromil Xanthines Acefylline Ambuphylline Bamifylline Doxofylline Enprofylline Etamiphylline Proxyphylline Theophylline/Aminophylline/Choline theophyllinate Eicosanoid inhibition Leukotriene antagonists Montelukast Pranlukast Zafirlukast Arachidonate 5-lipoxygenase inhibitors Zileuton Thromboxane receptor antagonists Ramatroban Seratrodast Non-xanthine PDE4 inhibitors Ibudilast Roflumilast Others/unknown Amlexanox Eprozinol Fenspiride‡ Omalizumab Combination products Aclidinium bromide/formoterol Beclometasone/formoterol Beclometasone/formoterol/glycopyrronium bromide Budesonide/formoterol Budesonide/glycopyrronium bromide/formoterol Fluticasone furoate/umeclidinium bromide/vilanterol Fluticasone furoate/vilanterol Fluticasone propionate/salmeterol Glycopyrronium bromide/formoterol Indacaterol/glycopyrronium bromide Indacaterol/glycopyrronium bromide/mometasone Indacaterol/mometasone Ipratropium bromide/salbutamol Mometasone/formoterol Umeclidinium bromide/vilanterol #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never to phase III v t e Ophthalmologicals: mydriasis and cycloplegia (S01F) Anticholinergics/antimuscarinics Atropine Scopolamine Methylscopolamine Cyclopentolate Homatropine Tropicamide Sympathomimetics Phenylephrine (+ketorolac) Ephedrine Ibopamine Acetylcholine receptor modulators v t e Muscarinic acetylcholine receptor modulators mAChRs Agonists 77-LH-28-1 AC-42 AC-260,584 Aceclidine Acetylcholine AF30 AF150(S) AF267B Alvameline AQRA-741 Arecoline Bethanechol Bevonium Butyrylcholine Carbachol CDD-0034 CDD-0078 CDD-0097 CDD-0098 CDD-0102 Cevimeline Choline cis-Dioxolane Clozapine Desmethylclozapine (norclozapine) Ethoxysebacylcholine Itameline LY-593,039 L-689,660 LY-2,033,298 McNA343 Methacholine Milameline Muscarine NGX-267 Ocvimeline Oxotremorine PD-151,832 Pilocarpine RS86 Sabcomeline SDZ 210-086 Sebacylcholine Suberyldicholine Talsaclidine Tazomeline Thiopilocarpine Vedaclidine VU-0029767 VU-0090157 VU-0152099 VU-0152100 VU-0238429 WAY-132,983 Xanomeline YM-796 Antagonists 3-Quinuclidinyl benzilate 4-DAMP Aclidinium bromide (+formoterol) Abediterol AF-DX 250 AF-DX 384 Ambutonium bromide Anisodamine Anisodine Antihistamines (first-generation) (e.g., brompheniramine, buclizine, captodiame, chlorphenamine (chlorpheniramine), cinnarizine, clemastine, cyproheptadine, dimenhydrinate, dimetindene, diphenhydramine, doxylamine, meclizine, mequitazine, perlapine, phenindamine, pheniramine, phenyltoloxamine, promethazine, propiomazine, triprolidine) AQ-RA 741 Atropine Atropine methonitrate Atypical antipsychotics (e.g., clozapine, fluperlapine, olanzapine (+fluoxetine), rilapine, quetiapine, tenilapine, zotepine) Benactyzine Benzatropine (benztropine) Benzilone Benzilylcholine mustard Benzydamine BIBN 99 Biperiden Bornaprine Camylofin CAR-226,086 CAR-301,060 CAR-302,196 CAR-302,282 CAR-302,368 CAR-302,537 CAR-302,668 Caramiphen Cimetropium bromide Clidinium bromide Cloperastine CS-27349 Cyclobenzaprine Cyclopentolate Darifenacin DAU-5884 Desfesoterodine Dexetimide DIBD Dicycloverine (dicyclomine) Dihexyverine Difemerine Diphemanil metilsulfate Ditran Drofenine EA-3167 EA-3443 EA-3580 EA-3834 Emepronium bromide Etanautine Etybenzatropine (ethybenztropine) Fenpiverinium Fentonium bromide Fesoterodine Flavoxate Glycopyrronium bromide (+beclometasone/formoterol, +indacaterol) Hexahydrodifenidol Hexahydrosiladifenidol Hexbutinol Hexocyclium Himbacine HL-031,120 Homatropine Imidafenacin Ipratropium bromide (+salbutamol) Isopropamide J-104,129 Hyoscyamine Mamba toxin 3 Mamba toxin 7 Mazaticol Mebeverine Meladrazine Mepenzolate Methantheline Methoctramine Methylatropine Methylhomatropine Methylscopolamine Metixene Muscarinic toxin 7 N-Ethyl-3-piperidyl benzilate N-Methyl-3-piperidyl benzilate Nefopam Octatropine methylbromide (anisotropine methylbromide) Orphenadrine Otenzepad (AF-DX 116) Otilonium bromide Oxapium iodide Oxitropium bromide Oxybutynin Oxyphencyclimine Oxyphenonium bromide PBID PD-102,807 PD-0298029 Penthienate Pethidine pFHHSiD Phenglutarimide Phenyltoloxamine Pipenzolate bromide Piperidolate Pirenzepine Piroheptine Pizotifen Poldine Pridinol Prifinium bromide Procyclidine Profenamine (ethopropazine) Propantheline bromide Propiverine Quinidine Revefenacin Rociverine RU-47,213 SCH-57,790 SCH-72,788 SCH-217,443 Scopolamine (hyoscine) Scopolamine butylbromide (hyoscine butylbromide) Silahexacyclium Sofpironium bromide Solifenacin SSRIs (e.g., femoxetine, paroxetine) Telenzepine Terodiline Tetracyclic antidepressants (e.g., amoxapine, maprotiline, mianserin, mirtazapine) Tiemonium iodide Timepidium bromide Tiotropium bromide Tiquizium bromide Tofenacin Tolterodine Tricyclic antidepressants (e.g., amitriptyline (+perphenazine), amitriptylinoxide, butriptyline, cidoxepin, clomipramine, desipramine, desmethyldesipramine, dibenzepin, dosulepin (dothiepin), doxepin, imipramine, lofepramine, nitroxazepine, northiaden (desmethyldosulepin), nortriptyline, protriptyline, quinupramine, trimipramine) Tridihexethyl Trihexyphenidyl Trimebutine Tripitamine (tripitramine) Tropacine Tropatepine Tropicamide Trospium chloride Typical antipsychotics (e.g., chlorpromazine, chlorprothixene, cyamemazine (cyamepromazine), loxapine, mesoridazine, thioridazine) Umeclidinium bromide (+vilanterol) WIN-2299 Xanomeline Zamifenacin Precursors (and prodrugs) Acetyl-coA Adafenoxate Choline (lecithin) Citicoline Cyprodenate Dimethylethanolamine Glycerophosphocholine Meclofenoxate (centrophenoxine) Phosphatidylcholine Phosphatidylethanolamine Phosphorylcholine Pirisudanol See also: Receptor/signaling modulators • Nicotinic acetylcholine receptor modulators • Acetylcholine metabolism/transport modulators v t e Nicotinic acetylcholine receptor modulators nAChRs Agonists (and PAMs) 5-HIAA 6-Chloronicotine A-84,543 A-366,833 A-582,941 A-867,744 ABT-202 ABT-418 ABT-560 ABT-894 Acetylcholine Altinicline Anabasine Anatabine Anatoxin-a AR-R17779 Bephenium hydroxynaphthoate Butinoline Butyrylcholine Carbachol Choline Cotinine Cytisine Decamethonium Desformylflustrabromine Dianicline Dimethylphenylpiperazinium Epibatidine Epiboxidine Ethanol (alcohol) Ethoxysebacylcholine EVP-4473 EVP-6124 Galantamine GTS-21 Ispronicline Ivermectin JNJ-39393406 Levamisole Lobeline MEM-63,908 (RG-3487) Morantel Nicotine (tobacco) NS-1738 PHA-543,613 PHA-709,829 PNU-120,596 PNU-282,987 Pozanicline Pyrantel Rivanicline RJR-2429 Sazetidine A SB-206553 Sebacylcholine SIB-1508Y SIB-1553A SSR-180,711 Suberyldicholine Suxamethonium (succinylcholine) Suxethonium (succinyldicholine) TC-1698 TC-1734 TC-1827 TC-2216 TC-5214 TC-5619 TC-6683 Tebanicline Tribendimidine Tropisetron UB-165 Varenicline WAY-317,538 XY-4083 Antagonists (and NAMs) 18-MAC 18-MC α-Neurotoxins (e.g., α-bungarotoxin, α-cobratoxin, α-conotoxin, many others) ABT-126 Alcuronium Allopregnanolone Amantadine Anatruxonium AQW051 Atracurium Barbiturates (e.g., pentobarbital, sodium thiopental) BNC-210 Bungarotoxins (e.g., α-bungarotoxin, κ-bungarotoxin) Bupropion BW284C51 BW-A444 Candocuronium iodide (chandonium iodide) Chlorisondamine Cisatracurium Coclaurine Coronaridine Curare Cyclopropane Dacuronium bromide Decamethonium Dehydronorketamine Desflurane Dextromethorphan Dextropropoxyphene Dextrorphan Diadonium DHβE Dihydrochandonium Dimethyltubocurarine (metocurine) Dioscorine Dipyrandium Dizocilpine (MK-801) Doxacurium Encenicline Enflurane Erythravine Esketamine Fazadinium Gallamine Gantacurium chloride Halothane Hexafluronium Hexamethonium (benzohexonium) Hydroxybupropion Hydroxynorketamine Ibogaine Isoflurane Ketamine Kynurenic acid Laudanosine Laudexium (laudolissin) Levacetylmethadol Levomethadone Malouetine ME-18-MC Mecamylamine Memantine Methadone Methorphan (racemethorphan) Methyllycaconitine Metocurine Mivacurium Morphanol (racemorphan) Neramexane Nitrous oxide Norketamine Pancuronium bromide Pempidine Pentamine Pentolinium Phencyclidine Pipecuronium bromide Progesterone Promegestone Radafaxine Rapacuronium bromide Reboxetine Rocuronium bromide Sevoflurane Stercuronium iodide Surugatoxin Thiocolchicoside Toxiferine Tramadol Trimetaphan camsilate (trimethaphan camsylate) Tropeinium Tubocurarine Vanoxerine Vecuronium bromide Xenon Precursors (and prodrugs) Acetyl-coA Adafenoxate Choline (lecithin) Citicoline Cyprodenate Dimethylethanolamine Glycerophosphocholine Meclofenoxate (centrophenoxine) Phosphatidylcholine Phosphatidylethanolamine Phosphorylcholine Pirisudanol See also: Receptor/signaling modulators • Muscarinic acetylcholine receptor modulators • Acetylcholine metabolism/transport modulators v t e Acetylcholine metabolism and transport modulators Enzyme (modulators) ChAT Inhibitors: 1-(-Benzoylethyl)pyridinium 2-(α-Naphthoyl)ethyltrimethylammonium 3-Chloro-4-stillbazole 4-(1-Naphthylvinyl)pyridine Acetylseco hemicholinium-3 Acryloylcholine AF64A B115 BETA CM-54,903 N,N-Dimethylaminoethylacrylate N,N-Dimethylaminoethylchloroacetate AChE Inhibitors: Reversible: Carbamates: Aldicarb Aminocarb Bendiocarb Bufencarb Carbaryl Carbendazim Carbetamide Carbofuran Carbosulfan Chlorbufam Chloropropham Dimetilan Ethienocarb Ethiofencarb Fenobucarb Formetanate Formparanate Methiocarb Methomyl Metolcarb Miotine Oxamyl Phenmedipham Pinmicarb Pirimicarb Promecarb Propamocarb Propham Propoxur Thiodicarb Thiofanox; Stigmines: Distigmine Eptastigmine Ganstigmine Neostigmine Phenserine Physostigmine Pyridostigmine Quilostigmine Rivastigmine Terestigmine; Others: Acotiamide Ambenonium Caffeine Donepezil EA-3990 EA-4056 Edrophonium Galantamine Huperzine A Huprine W Huprine X Huprine Y Ipidacrine Itopride Ladostigil Minaprine Octamethylene-bis(5-dimethylcarbamoxyisoquinolinium bromide) T-1123 TL-599 TL-1238 Tacrine Zanapezil Irreversible: Organophosphates: 2-Ethoxycarbonyl-1-methylvinyl cyclohexyl methylphosphonate Acephate Armine Azinphos-ethyl Azinphos-methyl BAY-29952 Bensulide Cadusafos Carbophenothion Chlorethoxyfos Chlorfenvinphos Chlorpyrifos Chlorpyrifos-methyl Coumaphos Crotylsarin Cyanophos Cyclosarin (GF) Demephion Demeton Demeton-S-methyl Dialifor Diazinon Dichlorvos Dicrotophos Diisopropylphosphate Dimefox Dimethoate Dimethyl 4-(methylthio)phenyl phosphate Dioxathion Disulfoton EA-2012 EA-2054 EA-2098 EA-2192 EA-2613 EA-3148 EA-4352 Echothiophate Ethylsarin (GE) Endothion EPN Ethion Ethoprop Fenamiphos Fenitrothion Fenthion Fluorotabun Fonofos Formothion Fosthiazate GD-42 GH GT-45 GV Guanitoxin Hexaethyl tetraphosphate (HETP) Isofluorophate Isoxathion Leptophos Malaoxon Malathion Mazidox Methamidophos Methidathion Methyl phenkapton Methylfluorophosphonylcholine (MFPCh) Metrifonate Mevinphos Mipafox Monocrotophos Naled Novichok agent Omethoate Oxydemeton-methyl Paraoxon Parathion Parathion-methyl Phorate Phosalone Phosfolan Phosmet Phosphamidon Phoxim Pirimiphos-methyl Profenofos Prothoate Ro 3-0340 Ro 3-0346 Ro 3-0347 Ro 3-0351 Ro 3-0352 Ro 3-0397 Ro 3-0411 Ro 3-0412 Ro 3-0417 Ro 3-0419 Ro 3-0422 Ro 3-0433 Ronnel Sarin (GB) Schradan Soman (GD) Sulfotep (TEDP) Tabun (GA) Tebupirimfos Temefos Terbufos Tetrachlorvinphos Tetraethyl pyrophosphate (TEPP) Triazofos Tribufos Trichlorfon Trichloronate Tricresyl phosphate VE VG VM VP VS VR VX; Others: Demecarium Fasciculins (green mamba toxins) (1, 2, 3, 4) Onchidal (Onchidella binneyi) Methanesulfonyl fluoride Unsorted: α-Pinene α-Viniferin Affinine Affinisine Arisugacin A Bulbocapnine Conodurine Coronaridine Corydaline Corynoline Crimidine Cyclanoline Cymserine Harmaline Kobophenol A Lactucopicrin Lycorine Phosacetim Rosmarinic acid Stercuronium iodide Taspine Tetrahydrocannabinol Ungeremine Ungiminorine Dimethylcarbamoyl fluoride BW284C51 TMTFA Reactivators: Asoxime chloride Methoxime Obidoxime Pralidoxime Trimedoxime bromide BChE Inhibitors: Affinine Affinisine Conodurine Cymserine Ladostigil Profenamine (ethopropazine) Rivastigmine Tacrine ZINC-12613047 Many of the other AChE inhibitors listed above Transporter (modulators) CHT Inhibitors: Hemicholinium-3 (hemicholine) Triethylcholine Enhancers: Coluracetam VAChT Inhibitors: Vesamicol Release (modulators) Inhibitors SNAP-25 inactivators: Botulinum toxin (A, C, E) VAMP inactivators: Botulinum toxin (B, D, F, G) Others: Bungarotoxins (β-bungarotoxin, γ-bungarotoxin) Enhancers LPHN agonists: α-Latrotoxin Others: Atracotoxins (e.g., robustoxin, versutoxin) Crotoxin See also: Receptor/signaling modulators • Muscarinic acetylcholine receptor modulators • Nicotinic acetylcholine receptor modulators